Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Heron Therapeutics, Inc. (HRTX)
Last heron therapeutics, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
herontherapeutics.gcs-web.com/investor-home
Company Research
Source: Yahoo! Finance
Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Performance Drivers The company successfully completed a financing round that eliminated a long-standing capital structure overhang, allowing management to focus entirely on commercial execution. Acute Care performance reached a strategic inflection point in Q4 2025, with ZYNRELEF and APONVIE delivering 48% and 97% year-over-year revenue growth, respectively. Operational improvements such as the CrossLink IGNITE distributor incentive program and the introduction of the vial access needle (VAN) significantly reduced hospital workflow friction. The implementation of permanent J-Codes for ZYNRELEF and APONVIE has improved reimbursement clarity, facilitating broader adoption across hospitals and ambulatory surgery centers. Oncology performance remained a stable revenue base, with CINVANTI showing resilience against competitive pressures while the company continues the planned wind-down of SU
Show less
Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HRTX alerts
High impacting Heron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HRTX
News
- Heron Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial ResultsGlobeNewswire
HRTX
Earnings
- 2/26/26 - Beat
HRTX
Analyst Actions
- 1/9/26 - HC Wainwright
HRTX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- HRTX's page on the SEC website